A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2011
06/29/2011	CN101357149B Cynanchum otophyllum schneid dispersible tablets and preparation method thereof
06/29/2011	CN101322758B Method for producing spina date seed extract using complex enzyme
06/29/2011	CN101304994B 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
06/29/2011	CN101288771B Preparation method of anti-human Nogo-66 receptor protein vaccine and application thereof
06/29/2011	CN101027301B Fused ring azadecalin glucocorticoid receptor modulators
06/28/2011	US7968716 Caspase inhibitors and uses thereof
06/28/2011	US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid
06/28/2011	US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby
06/28/2011	US7968597 Levodopa prodrug mesylate, compositions thereof, and uses thereof
06/28/2011	US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
06/28/2011	US7968546 Pyridazinone kinase inhibitors
06/28/2011	US7968545 Compositions useful as inhibitors of voltage-gated ion channels
06/28/2011	US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements
06/28/2011	US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
06/28/2011	US7968337 Neural precursor cells, method for the production and use thereof in neural defect therapy
06/28/2011	US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
06/28/2011	US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/28/2011	CA2635196C Glucocorticoid receptor modulators
06/28/2011	CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011	CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/28/2011	CA2427206C Sulfamides as gamma-secretase inhibitors
06/28/2011	CA2414772C Prevention and treatment of alzheimer's disease
06/28/2011	CA2413086C Benzothiazole derivatives
06/28/2011	CA2324301C Novel use of phospholipids of vegetable and animal origin in nutritional therapy
06/23/2011	WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	WO2011075596A1 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
06/23/2011	WO2011075525A1 Process for preparing cannabinoid receptor ligands
06/23/2011	WO2011075514A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
06/23/2011	WO2011075487A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
06/23/2011	WO2011074695A1 Shivering suppressor
06/23/2011	WO2011074690A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
06/23/2011	WO2011074637A1 Transdermally absorbed preparation of anti-dementia drug
06/23/2011	WO2011074636A1 Transdermally absorbed preparation of anti-dementia drug
06/23/2011	WO2011074635A1 Transdermally absorbed preparation of anti-dementia drug
06/23/2011	WO2011074519A1 Pharmaceutical composition for treatment and prevention of age-related memory impair
06/23/2011	WO2011073347A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/23/2011	WO2011073339A1 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
06/23/2011	WO2011073322A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
06/23/2011	WO2011073316A1 4-aryl-butane-1,3-diamides
06/23/2011	WO2011073299A1 Pyridinyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
06/23/2011	WO2011073296A1 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
06/23/2011	WO2011073286A1 Prostate specific membrane antigen inhibitors
06/23/2011	WO2011073207A1 Use of a neurofilament peptide for the treatment of glioma
06/23/2011	WO2011073172A1 Ethynyl derivatives
06/23/2011	WO2011073160A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
06/23/2011	WO2011073119A1 Mk2 inhibitors
06/23/2011	WO2011072697A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072696A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072695A1 Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors
06/23/2011	WO2011072694A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072691A1 Pyridone derivatives as nk3 antagonists
06/23/2011	WO2011072496A1 Epothilone compounds, preparation method and use thereof
06/23/2011	WO2011072484A1 Target and medicaments for treatment of brain injuries
06/23/2011	WO2011072483A1 Compositions and methods for controlling proliferation and differentiation cells
06/23/2011	WO2011051490A3 Heterocyclic derivatives
06/23/2011	WO2011017404A3 Retroelements and mental disorders and methods of measuring l1 retrotransposition
06/23/2011	US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
06/23/2011	US20110152381 3-keto-n-propargyl-1-aminoindan
06/23/2011	US20110152380 Paediatric Compositions For Treating Multiple Sclerosis
06/23/2011	US20110152362 Methods of treating epileptogenesis and epilepsy
06/23/2011	US20110152354 Bispecific Oligonucleotide for the Treatment of CNS Malignancies
06/23/2011	US20110152341 Cleavage of b-amyloid precursor protein
06/23/2011	US20110152334 Mglu2 agonists
06/23/2011	US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
06/23/2011	US20110152325 Carboxamide compounds and their use as calpain inhibitors iv
06/23/2011	US20110152320 Pyrrole derivatives, their preparation and their therapeutic application
06/23/2011	US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
06/23/2011	US20110152316 3,4-substituted piperidine derivatives as renin inhibitors
06/23/2011	US20110152309 Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter
06/23/2011	US20110152308 Aza-ring fused indole and indoline derivatives
06/23/2011	US20110152306 Aza-bridged ring-fused indoles and indolines
06/23/2011	US20110152299 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
06/23/2011	US20110152293 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
06/23/2011	US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/23/2011	US20110152286 Piperazine-substituted benzothiophenes for treatment of mental disorders
06/23/2011	US20110152284 Sigma ligands for neuronal regeneration and functional recovery
06/23/2011	US20110152280 Novel ergoline analogs
06/23/2011	US20110152265 Carboxamide compounds and their use as calpain inhibitors v
06/23/2011	US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
06/23/2011	US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor
06/23/2011	US20110152257 Ethynyl compounds useful for treatment of cns disorders
06/23/2011	US20110152256 1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE AND PYRAZOLO[4,3-e]-1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
06/23/2011	US20110152253 Spiroaminodihydrothiazine derivatives
06/23/2011	US20110152249 Evaluating central nervous system
06/23/2011	US20110152248 Bridgehead amine ring-fused indoles and indolines
06/23/2011	US20110152245 Substituted benzamides
06/23/2011	US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists
06/23/2011	US20110152241 Novel compounds as receptor modulators with therapeutic utility
06/23/2011	US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
06/23/2011	US20110152238 Pharmaceutical compounds
06/23/2011	US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
06/23/2011	US20110152234 Novel Compounds
06/23/2011	US20110152227 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
06/23/2011	US20110152226 Development of New Selective Estrogen Receptor Modulators
06/23/2011	US20110152214 Silk polymer-based adenosine release: therapeutic potential for epilepsy
06/23/2011	US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease
06/23/2011	US20110152205 Application of puerarin in the preparation of p2x3 mediated drugs for pain/nervous system diseases
06/23/2011	US20110152188 Pharmaceutical compositions of igf/i proteins
06/23/2011	US20110152183 Derivatised hybrid peptides of amylin and salmon calcitonin
06/23/2011	US20110152180 Bioactive pentapeptides from rice bran and use thereof

1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 1833